Series date: 
12/27/2023 - 11:30am EST to 12/31/2024 - 12:30pm EST

COURSE DESCRIPTION:  

A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration. The team discussion pertaining to diagnosis and treatment includes radiological and pathological findings and immunohistochemical testing to bridge gaps across the continuum of care and enhance the overall quality of patient-centered thoracic cancer care.

TARGET AUDIENCE:

Medical Oncologists, Radiation Oncologists, Cardiothoracic Surgeons, Pathologists, Pulmonologists, Pharmacists, Nurses, Occupational Therapists, Respiratory Therapists, Dietitians, Athletic Trainers, Patient Care Facilitators and all other personnel involved in the care of the lung and other thoracic cancer patient.  

LEARNING OBJECTIVES:

  • Implement the optimal course of treatment for thoracic cancer patients.
  • Develop a comprehensive treatment plan for thoracic oncology patients leveraging imaging, pathology and immunohistochemical results to meet radiology, pathology, surgery, medical oncology, radiation oncology and tumor board documentation standards of practice.
  • Determine cancer staging using various imaging modalities for thoracic cancers.
  • Promote a multidisciplinary team approach by bridging gaps across the continuum of care in order to enhance the overall quality of patient-centered thoracic cancer care. 

FACULTY AND DISCLOSURES:
Aurora Tiare Tekurio, RTT, moderator for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855957, by the Florida Boards of Medicine, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Occupational Therapists, Pharmacists and Pharmacy Techs, Respiratory Therapists (direct delivery),  Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.

image

American Board of Surgery - Maintenance of Certification (MOC) -   Accredited CME - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system. 

Series location: 
Lynn Cancer Institute
FL
United States

Sessions

Sessionsort descending Date
Lynn Cancer Institute Thoracic Oncology Tumor Board 04/15/2024 - 11:30am to 12:30pm EDT
Lynn Cancer Institute Thoracic Oncology Tumor Board 11/18/2024 - 11:30am to 12:30pm EST
Lynn Cancer Institute Thoracic Oncology Tumor Board 04/22/2024 - 11:30am to 12:30pm EDT
Lynn Cancer Institute Thoracic Oncology Tumor Board 11/25/2024 - 11:30am to 12:30pm EST
Lynn Cancer Institute Thoracic Oncology Tumor Board 04/29/2024 - 11:30am to 12:30pm EDT
Lynn Cancer Institute Thoracic Oncology Tumor Board 12/02/2024 - 11:30am to 12:30pm EST
Lynn Cancer Institute Thoracic Oncology Tumor Board 05/06/2024 - 11:30am to 12:30pm EDT
Lynn Cancer Institute Thoracic Oncology Tumor Board 12/09/2024 - 11:30am to 12:30pm EST
Lynn Cancer Institute Thoracic Oncology Tumor Board 05/13/2024 - 11:30am to 12:30pm EDT
Lynn Cancer Institute Thoracic Oncology Tumor Board 12/16/2024 - 11:30am to 12:30pm EST

Pages